A4GNT | Alpha-1,4-N-acetylglucosaminyltransferase | Predicted secreted proteins
| | | | | Tissue enriched |
ABR | Active BCR-related | | | | | | Expressed in all |
ACR | Acrosin | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
ACRBP | Acrosin binding protein | Predicted secreted proteins
| | | | | Tissue enriched |
ACSM5 | Acyl-CoA synthetase medium-chain family member 5 | Enzymes Mitochondrial proteins
| | | | | Tissue enriched |
ACTL7B | Actin-like 7B | | | | | | Tissue enriched |
ACTRT2 | Actin-related protein T2 | Cytoskeleton related proteins
| | | | | Tissue enriched |
ADAM20 | ADAM metallopeptidase domain 20 | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
ADAM21 | ADAM metallopeptidase domain 21 | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
ADAMTS20 | ADAM metallopeptidase with thrombospondin type 1 motif, 20 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Not detected |
ADCK5 | AarF domain containing kinase 5 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
ADGB | Androglobin | Enzymes
| | | | | Group enriched |
ADPRHL1 | ADP-ribosylhydrolase like 1 | | | | | | Group enriched |
AKR1B15 | Aldo-keto reductase family 1, member B15 | | | | | | Tissue enhanced |
ALLC | Allantoicase | Enzymes
| | | | | Tissue enriched |
ALPK1 | Alpha-kinase 1 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
ANKEF1 | Ankyrin repeat and EF-hand domain containing 1 | | | | | | Tissue enhanced |
ANKRD45 | Ankyrin repeat domain 45 | | | | | | Tissue enhanced |
ANKRD65 | Ankyrin repeat domain 65 | | | | | | Tissue enhanced |
ANO4 | Anoctamin 4 | Predicted membrane proteins
| | | | | Tissue enhanced |
AQP12A | Aquaporin 12A | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
AQP12B | Aquaporin 12B | Predicted membrane proteins
| | | | | Tissue enriched |
AQP3 | Aquaporin 3 (Gill blood group) | Blood group antigen proteins Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
AQP6 | Aquaporin 6, kidney specific | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
ARHGDIG | Rho GDP dissociation inhibitor (GDI) gamma | | | | | | Tissue enhanced |
ARMC3 | Armadillo repeat containing 3 | | | | | | Group enriched |
ASTE1 | Asteroid homolog 1 (Drosophila) | | | | | | Mixed |
ATP6V0D2 | ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2 | | | | | | Tissue enriched |
ATP6V1G3 | ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3 | Transporters
| | | | | Tissue enriched |
AZIN1 | Antizyme inhibitor 1 | | | | | | Expressed in all |
B3GNT7 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 | Predicted secreted proteins
| | | | | Tissue enhanced |
BBC3 | BCL2 binding component 3 | Mitochondrial proteins Plasma proteins
| | | | | Mixed |
BEND2 | BEN domain containing 2 | | | | | | Tissue enriched |
BEND6 | BEN domain containing 6 | | | | | | Tissue enriched |
BEST4 | Bestrophin 4 | Predicted membrane proteins
| | | | | Group enriched |
BHLHE22 | Basic helix-loop-helix family, member e22 | Transcription factors
| | | | | Tissue enhanced |
BPIFA3 | BPI fold containing family A, member 3 | Predicted secreted proteins
| | | | | Tissue enriched |
C10orf126 | Chromosome 10 open reading frame 126 | | | | | | Tissue enriched |
C10orf53 | Chromosome 10 open reading frame 53 | | | | | | Tissue enriched |
C10orf67 | Chromosome 10 open reading frame 67 | | | | | | Group enriched |
C10orf99 | Chromosome 10 open reading frame 99 | Predicted secreted proteins
| | | | | Group enriched |
C11orf42 | Chromosome 11 open reading frame 42 | | | | | | Tissue enriched |
C12orf56 | Chromosome 12 open reading frame 56 | | | | | | Tissue enhanced |
C12orf60 | Chromosome 12 open reading frame 60 | | | | | | Tissue enhanced |
C14orf39 | Chromosome 14 open reading frame 39 | Plasma proteins
| | | | | Tissue enhanced |
C15orf48 | Chromosome 15 open reading frame 48 | | | | | | Tissue enhanced |
C17orf47 | Chromosome 17 open reading frame 47 | | | | | | Tissue enriched |
C17orf78 | Chromosome 17 open reading frame 78 | Predicted membrane proteins
| | | | | Group enriched |
C17orf97 | Chromosome 17 open reading frame 97 | | | | | | Tissue enhanced |
C19orf18 | Chromosome 19 open reading frame 18 | Predicted membrane proteins
| | | | | Tissue enriched |